These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2444929)

  • 21. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications.
    Klein RC; Machell C
    J Am Coll Cardiol; 1989 Jul; 14(1):155-61; discussion 162-3. PubMed ID: 2738260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation mapping in patients with coronary artery disease with multiple ventricular tachycardia configurations: occurrence and therapeutic implications of widely separate apparent sites of origin.
    Waspe LE; Brodman R; Kim SG; Matos JA; Johnston DR; Scavin GM; Fisher JD
    J Am Coll Cardiol; 1985 May; 5(5):1075-86. PubMed ID: 3989117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antagonism of quinidine's electrophysiologic effects by epinephrine in patients with ventricular tachycardia.
    Morady F; Kou WH; Kadish AH; Nelson SD; Toivonen LK; Kushner JA; Schmaltz S; de Buitleir M
    J Am Coll Cardiol; 1988 Aug; 12(2):388-94. PubMed ID: 3392332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug response at electropharmacologic study in patients with ventricular tachyarrhythmias: the importance of ventricular refractoriness.
    Gillis AM; Wyse DG; Duff HJ; Mitchell LB
    J Am Coll Cardiol; 1991 Mar; 17(4):914-20. PubMed ID: 1999629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction.
    Roy D; Marchand E; Théroux P; Waters DD; Pelletier GB; Cartier R; Bourassa MG
    J Am Coll Cardiol; 1986 Jul; 8(1):32-9. PubMed ID: 3711529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in sudden death and total mortality by antiarrhythmic therapy evaluated by electrophysiologic drug testing: criteria of efficacy in patients with sustained ventricular tachyarrhythmia.
    Waller TJ; Kay HR; Spielman SR; Kutalek SP; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1987 Jul; 10(1):83-9. PubMed ID: 3597999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of nadolol alone or in combination with a type IA antiarrhythmic drug in sustained ventricular tachycardia: a prospective study.
    Munsif AN; Saksena S
    Pacing Clin Electrophysiol; 1989 Nov; 12(11):1816-26. PubMed ID: 2478982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid self-terminating ventricular tachycardia induced during electrophysiologic study: a prospective evaluation.
    Sager PT; Perlmutter RA; Rosenfeld LE; McPherson CA; Batsford WP
    J Am Coll Cardiol; 1989 Feb; 13(2):385-90. PubMed ID: 2913116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.
    Platia EV; Reid PR
    J Am Coll Cardiol; 1984 Sep; 4(3):493-500. PubMed ID: 6470328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amiodarone therapy: role of early and late electrophysiologic studies.
    Greenspon AJ; Volosin KJ; Greenberg RM; Jefferies L; Rotmensch HH
    J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.
    Zhu J; Haines DE; Lerman BB; DiMarco JP
    Circulation; 1987 Oct; 76(4):802-9. PubMed ID: 3652422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.
    Lerman BB; Waxman HL; Buxton AE; Josephson ME
    Am J Cardiol; 1983 Mar; 51(5):759-64. PubMed ID: 6829435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of successful suppression of sustained ventricular tachyarrhythmias by serial drug testing from data derived at the initial electrophysiologic study.
    Kuchar DL; Rottman J; Berger E; Freeman CS; Garan H; Ruskin JN
    J Am Coll Cardiol; 1988 Oct; 12(4):982-8. PubMed ID: 3047198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular fibrillation survivors in whom tachyarrhythmia cannot be induced: outcome related to selected therapy.
    Kron J; Kudenchuk PJ; Murphy ES; Morris CD; Griffith K; Walance CG; McAnulty JH
    Pacing Clin Electrophysiol; 1987 Nov; 10(6):1291-300. PubMed ID: 2446276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.